Pfizer Inc. is a global pharmaceutical company headquartered in New York City, United States. The company was founded in 1849 by cousins Charles Pfizer and Charles Erhart and has since become one of the largest pharmaceutical companies in the world.Â
Pfizer’s market capitalization stands at approximately $309 billion USD, making it one of the largest pharmaceutical companies in the world.Â
Pfizer‘s patent portfolio stands as a testament to its innovation and industry leadership, boasting 490Â active patent families, 561 that are no longer active, and 383Â pending. This impressive collection underscores Pfizer’s significant global influence and its unwavering commitment to advancing autonomous industry across various sectors.
Contact Our Expert for Assistance
This Pie Chart Shows the number of active, pending and dead patents.
Pfizer have 873 alive and 561 dead patent families.
Pfizer patents are filed in numerous countries, reflecting its international presence and the strategic importance of protecting its inventions across the globe. The Pfizer countries list 2023 includes major markets where Pfizer operates and maintains its pharmaceutical leadership.Â
IPC Classification | Category |
Medicinal preparations containing organic active ingredients | (A61K31) |
Antineoplastic agents | (A61P35) |
Medicinal preparations containing antigens or antibodies | (A61K39) |
Heterocyclic compounds containing two or more hetero rings | (C07D401) |
Immunoglobulins, e.g. monoclonal or polyclonal antibodies | (C07K16) |
Drugs for disorders of the nervous system | (A61P25) |
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient | (A61K47) |
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics | (A61P31) |
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00-C07D477/00 | (C07D487) |
Medicinal preparations characterised by special physical form | (A61K9) |
Pfizer patents are diverse, covering a range of IPC classifications from Medicinal preparations containing organic active ingredients (A61K31) to Medicinal preparations characterised by special physical form (A61K9). Pfizer stats reveal that the company not only focuses on current medical needs but also paves the way for future advancements. Â
Feature | A61K31 (Medicinal Preparations) | A61P35 (Processes for Preparing or Treating Body Fluids) |
Focus of Innovation | Development of new drugs and formulations using organic active ingredients | Processes for treatment and preparation of body fluids (e.g., blood, dialysis solutions) |
Key Technological Advancements | Novel drug delivery systems (nanoparticles, liposomes). | Advanced filtration and purification techniques, Biocompatible materials for medical devices. |
Top Patent Filing Subcategories | New drug delivery systems, Bioactive compounds, Gene therapy and targeted drug delivery. | Dialysis membrane technology, Blood purification methods, Extracorporeal circulation techniques. |
Impact on Industries | Pharmaceuticals, biotechnology, personalized medicine. | Medical devices, dialysis equipment, blood purification services. |
Projected Future Trends | Increasing focus on personalized medicine and targeted therapies, Development of bioengineered drugs and gene editing technologies, Integration of artificial intelligence for drug discovery and development. | Advancements in point-of-care diagnostics and personalized blood treatment, Development of closed-loop artificial blood systems, Exploration of bioprinting and biofabrication for organ and tissue regeneration. |
Comparing different aspects of pfizer patents, such as Medicinal Preparations and Methods for Processes for Preparing or Treating Body Fluids, highlights the company’s foresight in areas like medical devices and pharmaceutical industry. These trends are indicative of where pfizer inventions are steering the future of technology. Â
The Chart below depicts the patents with most number of forward citations. These patents are likely to be the source of advancement in the domain and can be considered as valuable and core inventions.Â
Pfizer Inc., with its extensive patent portfolio covering a range of innovative technologies, stands as a key player in the pharmaceutical industry. The company has successfully secured a multitude of patents worldwide, emphasizing advancements in medicinal preparations and medical devices.
The data from 2013 to 2023 shows a proactive approach in patent applications across various countries, though the success rate has varied. Pfizer’s forward-thinking in addressing future medical needs is evident from its diverse patent classifications and its investment in emerging technologies, solidifying its role in shaping the future of healthcare and medical science.
Note: This Data is extracted from 2013 to 2023 and on the basis of patent families.
At TT Consultants, we're a premier provider of custom intellectual property (IP), technology intelligence, business research, and innovation support. Our approach blends AI and Large Language Model (LLM) tools with human expertise, delivering unmatched solutions.
Our team includes skilled IP experts, tech consultants, former USPTO examiners, European patent attorneys, and more. We cater to Fortune 500 companies, innovators, law firms, universities, and financial institutions.
Services:
Choose TT Consultants for tailored, top-quality solutions that redefine intellectual property management.
Contact Us
With 150 Million+ Patents and 220 Million+ Research Publications in its database, provides quick actionable insights into current trends and future outlook of technology through technology lens.Â
Our proprietary thesaurus that contains 3 billion+ technical words. This technical corpus helps our patent searchers quickly identify synonymous and interoperable words for comprehensive searches.
Request a Call Back!
Thank you for your interest in TT Consultants. Please fill out the form and we will contact you shortly
UNLOCK THE POWER
Of Your Ideas
Elevate Your Patent Knowledge
Exclusive Insights Await in Our Newsletter
Request a Call Back!
Thank you for your interest in TT Consultants. Please fill out the form and we will contact you shortly
